126 related articles for article (PubMed ID: 38883784)
41. High-Throughput Screening Identifies Inhibitors for Parvovirus B19 Infection of Human Erythroid Progenitors.
Ning K; Roy A; Cheng F; Xu P; Kleiboeker S; Escalante CR; Wang J; Qiu J
J Virol; 2022 Jan; 96(2):e0132621. PubMed ID: 34669461
[TBL] [Abstract][Full Text] [Related]
42. Human Parvovirus B19 Utilizes Cellular DNA Replication Machinery for Viral DNA Replication.
Zou W; Wang Z; Xiong M; Chen AY; Xu P; Ganaie SS; Badawi Y; Kleiboeker S; Nishimune H; Ye SQ; Qiu J
J Virol; 2018 Mar; 92(5):. PubMed ID: 29237843
[TBL] [Abstract][Full Text] [Related]
43. Frequency and significance of parvovirus B19 infection in patients with rheumatoid arthritis.
Naciute M; Mieliauskaite D; Rugiene R; Nikitenkiene R; Jancoriene L; Mauricas M; Nora-Krukle Z; Murovska M; Girkontaite I
J Gen Virol; 2016 Dec; 97(12):3302-3312. PubMed ID: 27902343
[TBL] [Abstract][Full Text] [Related]
44. The 11-Kilodalton Nonstructural Protein of Human Parvovirus B19 Facilitates Viral DNA Replication by Interacting with Grb2 through Its Proline-Rich Motifs.
Xu P; Chen AY; Ganaie SS; Cheng F; Shen W; Wang X; Kleiboeker S; Li Y; Qiu J
J Virol; 2019 Jan; 93(1):. PubMed ID: 30282717
[TBL] [Abstract][Full Text] [Related]
45. VP1u phospholipase activity is critical for infectivity of full-length parvovirus B19 genomic clones.
Filippone C; Zhi N; Wong S; Lu J; Kajigaya S; Gallinella G; Kakkola L; Söderlund-Venermo M; Young NS; Brown KE
Virology; 2008 May; 374(2):444-52. PubMed ID: 18252260
[TBL] [Abstract][Full Text] [Related]
46. RNA Binding Protein RBM38 Regulates Expression of the 11-Kilodalton Protein of Parvovirus B19, Which Facilitates Viral DNA Replication.
Ganaie SS; Chen AY; Huang C; Xu P; Kleiboeker S; Du A; Qiu J
J Virol; 2018 Apr; 92(8):. PubMed ID: 29437973
[TBL] [Abstract][Full Text] [Related]
47. Structures and implications of the nuclease domain of human parvovirus B19 NS1 protein.
Zhang Y; Shao Z; Gao Y; Fan B; Yang J; Chen X; Zhao X; Shao Q; Zhang W; Cao C; Liu H; Gan J
Comput Struct Biotechnol J; 2022; 20():4645-4655. PubMed ID: 36090819
[TBL] [Abstract][Full Text] [Related]
48. Phospholipase A2-like activity of human bocavirus VP1 unique region.
Qu XW; Liu WP; Qi ZY; Duan ZJ; Zheng LS; Kuang ZZ; Zhang WJ; Hou YD
Biochem Biophys Res Commun; 2008 Jan; 365(1):158-63. PubMed ID: 17981142
[TBL] [Abstract][Full Text] [Related]
49. Phospholipase A2 activity-dependent stimulation of Ca2+ entry by human parvovirus B19 capsid protein VP1.
Lupescu A; Bock CT; Lang PA; Aberle S; Kaiser H; Kandolf R; Lang F
J Virol; 2006 Nov; 80(22):11370-80. PubMed ID: 16956939
[TBL] [Abstract][Full Text] [Related]
50. Prevalence and Genotypes of Parvovirus B19 Among HIV Positive Children in Ibadan, Oyo State, Nigeria.
Aleru BO; Olusola BA; Faneye AO; Odaibo GN; Olaleye DO
Arch Basic Appl Med; 2018 Feb; 6(1):113-117. PubMed ID: 30003139
[TBL] [Abstract][Full Text] [Related]
51. Safety and immunogenicity of parvovirus B19 virus-like particle vaccine lacking phospholipase A2 activity.
Suzuki H; Noguchi T; Matsugu N; Suzuki A; Kimura S; Onishi M; Kosaka M; Miyazato P; Morita E; Ebina H
Vaccine; 2022 Oct; 40(42):6100-6106. PubMed ID: 36114131
[TBL] [Abstract][Full Text] [Related]
52. Existence of various human parvovirus B19 genotypes in Chinese plasma pools: genotype 1, genotype 3, putative intergenotypic recombinant variants and new genotypes.
Jia J; Ma Y; Zhao X; Huangfu C; Zhong Y; Fang C; Fan R; Lv M; Zhang J
Virol J; 2016 Sep; 13(1):155. PubMed ID: 27639978
[TBL] [Abstract][Full Text] [Related]
53. High-Resolution Structure of the Nuclease Domain of the Human Parvovirus B19 Main Replication Protein NS1.
Sanchez JL; Ghadirian N; Horton NC
J Virol; 2022 May; 96(9):e0216421. PubMed ID: 35435730
[TBL] [Abstract][Full Text] [Related]
54. Generation of multifunctional murine monoclonal antibodies specifically directed to the VP1unique region protein of human parvovirus B19.
Drechsler MD; Obermeier I; Döring Y; Lackner KJ; Modrow S; von Landenberg P
Immunobiology; 2008; 213(6):511-7. PubMed ID: 18514753
[TBL] [Abstract][Full Text] [Related]
55. Molecular-genetic characterization of human parvovirus B19 prevalent in Kerala State, India.
Seetha D; Pillai HR; Nori SRC; Kalpathodi SG; Thulasi VP; Nair RR
Virol J; 2021 May; 18(1):96. PubMed ID: 33952289
[TBL] [Abstract][Full Text] [Related]
56. Antibody-mediated enhancement of parvovirus B19 uptake into endothelial cells mediated by a receptor for complement factor C1q.
von Kietzell K; Pozzuto T; Heilbronn R; Grössl T; Fechner H; Weger S
J Virol; 2014 Jul; 88(14):8102-15. PubMed ID: 24807719
[TBL] [Abstract][Full Text] [Related]
57. Recent Advances in Replication and Infection of Human Parvovirus B19.
Ganaie SS; Qiu J
Front Cell Infect Microbiol; 2018; 8():166. PubMed ID: 29922597
[TBL] [Abstract][Full Text] [Related]
58. Significant association of past parvovirus B19 infection with cytopenia in both adult-onset Still's disease and systemic lupus erythematosus patients.
Chen DY; Chen YM; Lan JL; Tzang BS; Lin CC; Hsu TC
Clin Chim Acta; 2012 May; 413(9-10):855-60. PubMed ID: 22309679
[TBL] [Abstract][Full Text] [Related]
59. Human parvovirus B19 surveillance in patients with rash and fever from Belarus.
Yermalovich MA; Hübschen JM; Semeiko GV; Samoilovich EO; Muller CP
J Med Virol; 2012 Jun; 84(6):973-8. PubMed ID: 22499021
[TBL] [Abstract][Full Text] [Related]
60. Adeno-Associated Virus VP1u Exhibits Protease Activity.
Kurian JJ; Lakshmanan R; Chmely WM; Hull JA; Yu JC; Bennett A; McKenna R; Agbandje-McKenna M
Viruses; 2019 Apr; 11(5):. PubMed ID: 31035643
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
